News

Published on 6 Oct 2023 on Zacks via Yahoo Finance

The Zacks Analyst Blog Highlights Novavax, ALX Oncology, Regeneron Pharmaceuticals, Intellia and...

Article preview image

For Immediate Release

Chicago, IL – October 6, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Novavax, Inc. NVAX, ALX Oncology Holdings Inc. ALXO, Regeneron Pharmaceuticals, Inc. REGN, Intellia Therapeutics, Inc. NTLA and Moderna MRNA.

Here are highlights from Thursday’s Analyst Blog:

Read the rest of the article
NASDAQ.NVAX price evolution
NASDAQ.MRNA price evolution
NASDAQ.REGN price evolution
NASDAQ.NTLA price evolution
NASDAQ.ALXO price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regene...

Insider Monkey via Yahoo Finance 3 May 2024
Regeneron Pharmaceuticals Targets Quality Weight Loss In Latest Obesity Innovation - Regeneron...

On Thursday, Regeneron Pharmaceuticals Inc REGN reported first-quarter adjusted EPS of $9.55, dow...

Benzinga 2 May 2024
Is Weakness In Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock A Sign That The Market Could be...

It is hard to get excited after looking at Regeneron Pharmaceuticals' (NASDAQ:REGN) recent perfor...

Simply Wall St. via Yahoo Finance 2 May 2024
Decoding Regeneron Pharmaceuticals Inc (REGN): A Strategic SWOT Insight

Regeneron showcases robust product sales growth amidst competitive pharmaceutical landscape.Strat...

GuruFocus.com via Yahoo Finance 2 May 2024
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales

Regeneron Pharmaceuticals, Inc. REGN delivered lower-than-expected first-quarter 2024 results due...

Zacks via Yahoo Finance 2 May 2024
Regeneron's blockbuster eye drug posts weaker sales due to inventory impact

(Reuters) -U.S. drugmaker Regeneron Pharmaceuticals Inc missed Wall Street estimates for quarterl...

Reuters via Yahoo Finance 1 May 2024
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?

The first-quarter 2024 reporting cycle of the Medical sector is currently in full swing. The sect...

Zacks via Yahoo Finance 30 Apr 2024
Should You Consider Regeneron (REGN) Ahead of Q1 Earnings?

Biotech giant Regeneron Pharmaceuticals, Inc. REGN is slated to report first-quarter results on M...

Zacks via Yahoo Finance 30 Apr 2024
11 Oversold Growth Stocks to Buy Right Now

In this article, we will take a look at the 11 oversold growth stocks to buy right now. To skip o...

Insider Monkey via Yahoo Finance 28 Apr 2024
Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies

Regeneron Pharmaceuticals and Mammoth Biosciences join forces to develop CRISPR-based gene editin...

Seeking Alpha 25 Apr 2024

Copyright Statfolio @ 2024

Social Accounts